AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
Portfolio Pulse from Lisa Levin
AngioDynamics is expected to post quarterly earnings of 2 cents per share on revenue of $90.73 million. Disney is exploring strategic options for its India digital and TV business. MillerKnoll is expected to have earned 39 cents per share on revenue of $945.56 million for the latest quarter. ImmuCell reported preliminary sales of $3.53 million for Q2, down from $3.86 million in the previous year. Azitra named Travis Whitfill as Chief Operating Officer.
July 12, 2023 | 8:06 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
AngioDynamics is expected to post quarterly earnings of 2 cents per share on revenue of $90.73 million.
The earnings report could impact the stock price depending on whether the actual results meet, exceed, or fall short of expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Azitra named Travis Whitfill as Chief Operating Officer.
The appointment of a new COO could impact the stock price depending on investor perception of the new executive.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEUTRAL IMPACT
Disney is exploring strategic options for its India digital and TV business.
The strategic options could impact the stock price depending on the potential for growth in the India market.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEUTRAL IMPACT
MillerKnoll is expected to have earned 39 cents per share on revenue of $945.56 million for the latest quarter.
The earnings report could impact the stock price depending on whether the actual results meet, exceed, or fall short of expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
ImmuCell reported preliminary sales of $3.53 million for Q2, down from $3.86 million in the previous year.
The decrease in sales could negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100